Activating enhancer-binding protein-2β Nucleolar localization predicts poor survival after stage i non-small cell lung cancer resection

Annals of Thoracic Surgery

Volumn 92, Issue 3, 2011, Pages 1044-1050

  Kim, Min P ^a   Chen, Ying ^a   Bekele, B Nebiyou ^a   Lopez, Adriana ^a   Khanna, Abha ^a   Chen, Jie Qing ^a   Spitz, Margaret R ^a   Behrens, Carmen ^a   Solis, Luisa ^a   Wismach, Marnie ^a   Ji, Lin ^a   Wistuba, Ignacio I ^a   Roth, Jack A ^a   Katz, Ruth L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING ENHANCER BINDING PROTEIN 2 BETA; BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR LOCALIZATION SIGNAL; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY;

AGED; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL NUCLEUS; CYTOPLASM; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TEXAS; TRANSCRIPTION FACTOR AP-2; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 80052786965     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.04.029     Document Type: Article

References (17)

1. J.C. Nesbitt, J.B. Putnam, and G.L. Walsh Survival in early-stage non-small cell lung cancer Ann Thorac Surg 60 1995 466 472
2. P. Yan, J. Benhattar, and W. Seelentag Immunohistochemical localization of hTERT protein in human tissues Histochem Cell Biol 121 2004 391 397 (Pubitemid 38756936)
3. K.T. Etheridge, S.S. Banik, and B.N. Armbruster The nucleolar localization domain of the catalytic subunit of human telomerase J Biol Chem 277 2002 24764 24770 (Pubitemid 34952008)
4. L. Wang, J.C. Soria, and B.L. Kemp hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer Clin Cancer Res 8 2002 2883 2889 (Pubitemid 35025735)
5. D. Eckert, S. Buhl, and S. Weber The AP-2 family of transcription factors Genome Biol 6 2005 246
6. H. Ma, V. Urquidi, and J. Wong Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells Mol Cancer Res 1 2003 739 746 (Pubitemid 37025592)
7. X. Ding, C. Fan, and J. Zhou GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation Nucleic Acids Res 34 2006 2570 2578 (Pubitemid 43985621)
8. T. Williams, A. Admon, and B. Luscher Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements Genes Dev 2 1988 1557 1569
9. M. Moser, A. Imhof, and A. Pscherer Cloning and characterization of a second AP-2 transcription factor: AP-2 beta Development 121 1995 2779 2788
10. J.M. Bosher, N.F. Totty, and J.J. Hsuan A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma Oncogene 13 1996 1701 1707 (Pubitemid 26377502)
11. M. Moser, A. Pscherer, and C. Roth Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta Genes Dev 11 1997 1938 1948 (Pubitemid 27332981)
12. M. Nishizaki, J. Sasaki, and B. Fang Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells Cancer Res 64 2004 5745 5752 (Pubitemid 39095573)
13. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714 (Pubitemid 47357522)
14. K. Hilger-Eversheim, M. Moser, and H. Schorle Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control Gene 260 2000 1 12 (Pubitemid 32008495)
15. C.Q. Zhu, W. Shih, and C.H. Ling Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation J Clin Pathol 59 2006 790 800 (Pubitemid 44211740)
16. J. Albanell, F. Lonardo, and V. Rusch High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage J Natl Cancer Inst 89 1997 1609 1615 (Pubitemid 27479721)
17. M. Horky, V. Kotala, and M. Anton Nucleolus and apoptosis Ann NY Acad Sci 973 2002 258 264 (Pubitemid 36125016)